These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 10901463)
1. Optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast. Gommans GM; Boer RO; van Dongen A; van der Schors TG; de Waard JW Eur J Nucl Med; 2000 Jun; 27(6):744. PubMed ID: 10901463 [No Abstract] [Full Text] [Related]
2. 99mTc Nanocoll: a radiopharmaceutical for sentinel node localisation in breast cancer--in vitro and in vivo results. Gommans GM; Gommans E; van der Zant FM; Teule GJ; van der Schors TG; de Waard JW Appl Radiat Isot; 2009 Sep; 67(9):1550-8. PubMed ID: 19328701 [TBL] [Abstract][Full Text] [Related]
3. Methodology of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast. Bourgeois P; Leduc O; Belgrado JP; Leduc A Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):831-2; author reply 832-3. PubMed ID: 12029559 [No Abstract] [Full Text] [Related]
4. [Usefulness of scintigraphy of the parasternal lymph nodes using 99mTc-NANOCOLL for planning supplementary radiotherapy in patients with breast cancer]. Jabłkowski W; Wojciechowski A; Studniarek M; Pertyński T; Berner J; Wrezel B Pol Przegl Radiol; 1988; 52(6):274-8. PubMed ID: 3268815 [No Abstract] [Full Text] [Related]
5. Further optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling. Gommans GM; van Dongen A; van der Schors TG; Gommans E; Visser JF; Clarijs WW; de Waard JW; van de Bos J; Boer RO Eur J Nucl Med; 2001 Oct; 28(10):1450-5. PubMed ID: 11685486 [TBL] [Abstract][Full Text] [Related]
6. In search of the true sentinel node by different injection techniques in breast cancer patients. Roumen RM; Geuskens LM; Valkenburg JG Eur J Surg Oncol; 1999 Aug; 25(4):347-51. PubMed ID: 10419702 [TBL] [Abstract][Full Text] [Related]
7. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729 [TBL] [Abstract][Full Text] [Related]
9. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757 [TBL] [Abstract][Full Text] [Related]
10. [The importance of lymphoscintigraphy in breast cancer]. Kanaev SV; Semiglazov VF; Bykov SA; Mironov EE; Zhdanova VI Vopr Onkol; 1989; 35(11):1310-4. PubMed ID: 2609519 [TBL] [Abstract][Full Text] [Related]
11. [Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma]. Meijer S; Collet GJ; Pijpers HJ; van Hattum L; Hoekstra OS Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2239-43. PubMed ID: 8984370 [TBL] [Abstract][Full Text] [Related]
12. Preparation of 99mTc-Nanocoll for use in sentinel node localization: Validation of a protocol for supplying in unit-dose syringes. O'Brien LM; Duffin R; Millar AM Nucl Med Commun; 2006 Dec; 27(12):999-1003. PubMed ID: 17088686 [TBL] [Abstract][Full Text] [Related]
13. Blue dye and 99mTc-labeled human serum albumin: sentinel node detection by magic bullets? Wallace AM; Vera DR; Stadalnik RC J Nucl Med; 1999 Jul; 40(7):1149-50. PubMed ID: 10405135 [No Abstract] [Full Text] [Related]
14. Current status of commercial colloidal preparations for sentinel lymph node detection. Chinol M; Paganelli G Eur J Nucl Med; 1999 May; 26(5):560. PubMed ID: 10382101 [No Abstract] [Full Text] [Related]
15. Optimized sentinel node scintigraphy in breast cancer. Paganelli G; De Cicco C; Cremonesi M; Prisco G; Calza P; Luini A; Zucali P; Veronesi U Q J Nucl Med; 1998 Mar; 42(1):49-53. PubMed ID: 9646645 [TBL] [Abstract][Full Text] [Related]
16. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145 [TBL] [Abstract][Full Text] [Related]
17. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience]. Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092 [TBL] [Abstract][Full Text] [Related]
18. [Parasternal lymphoscintigraphy in planning the radiation therapy of breast cancer]. Bykov SA; Mironov EE; Zhdanova VI Med Radiol (Mosk); 1990 Jul; 35(7):13-7. PubMed ID: 2165205 [TBL] [Abstract][Full Text] [Related]
20. [Value of axillary lymphoscintigraphy using technetium 99Tcm Nanocoll in the diagnosis of breast cancer]. Jabłkowski W; Studniarek M; Wojciechowski A; Pertyński T Pol Przegl Radiol; 1986; 50(6):313-6. PubMed ID: 3302981 [No Abstract] [Full Text] [Related] [Next] [New Search]